Aqua Bio Technology ASA
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is b… Read more
Market Cap & Net Worth: Aqua Bio Technology ASA (ABTEC)
Aqua Bio Technology ASA (OL:ABTEC) has a market capitalization of $97.72 Million (Nkr1.11 Billion) as of March 18, 2026. Listed on the OL stock exchange, this Norway-based company holds position #29965 globally and #177 in its home market, demonstrating a -5.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aqua Bio Technology ASA's stock price Nkr6.90 by its total outstanding shares 161383937 (161.38 Million).
Aqua Bio Technology ASA Market Cap History: 2015 to 2026
Aqua Bio Technology ASA's market capitalization history from 2015 to 2026. Data shows change from $165.87 Million to $97.72 Million (-6.03% CAGR).
Aqua Bio Technology ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aqua Bio Technology ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.63x
Aqua Bio Technology ASA's market cap is 2.63 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $119.95 Million | $1.21 Million | -$16.06 Million | 98.82x | N/A |
| 2018 | $33.14 Million | $878.14K | -$38.47 Million | 37.74x | N/A |
| 2019 | $33.14 Million | $891.47K | -$13.22 Million | 37.18x | N/A |
| 2020 | $83.57 Million | $444.38K | -$14.70 Million | 188.06x | N/A |
| 2021 | $186.97 Million | $1.56 Million | -$19.11 Million | 119.87x | N/A |
| 2022 | $103.26 Million | $7.02 Million | -$18.74 Million | 14.72x | N/A |
| 2023 | $48.44 Million | $18.41 Million | -$21.02 Million | 2.63x | N/A |
Competitor Companies of ABTEC by Market Capitalization
Companies near Aqua Bio Technology ASA in the global market cap rankings as of March 18, 2026.
Key companies related to Aqua Bio Technology ASA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Aqua Bio Technology ASA Historical Marketcap From 2015 to 2026
Between 2015 and today, Aqua Bio Technology ASA's market cap moved from $165.87 Million to $ 97.72 Million, with a yearly change of -6.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr97.72 Million | +1404.69% |
| 2025 | Nkr6.49 Million | -78.17% |
| 2024 | Nkr29.74 Million | -38.60% |
| 2023 | Nkr48.44 Million | -53.09% |
| 2022 | Nkr103.26 Million | -44.77% |
| 2021 | Nkr186.97 Million | +123.73% |
| 2020 | Nkr83.57 Million | +152.14% |
| 2019 | Nkr33.14 Million | 0.00% |
| 2018 | Nkr33.14 Million | -72.37% |
| 2017 | Nkr119.95 Million | -2.64% |
| 2016 | Nkr123.20 Million | -25.73% |
| 2015 | Nkr165.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Aqua Bio Technology ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $97.72 Million USD |
| MoneyControl | $97.72 Million USD |
| MarketWatch | $97.72 Million USD |
| marketcap.company | $97.72 Million USD |
| Reuters | $97.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.